Delivery Order SPE2DB20D1109-SPE2DB25FP72F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lisdexamfetamine 10 mg capsules (90-count units) with a ceiling value of $1,132.24. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award represents a routine pharmaceutical procurement under the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) with a contract ceiling value of $1,339.45. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is located at the contractor's corporate office in Conshohocken, PA, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $1,629.94. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be supplied from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) with a contract ceiling value of $2,727.39. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 10 mg capsules (90-count packages) with a ceiling value of $1,348.89. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100-count) with a ceiling value of $1,474.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,125.58 and has an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp will perform this contract from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,211.46 delivery order contract to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by September 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $7,920.33. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP72FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $2,853.60. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents performance at the contractor's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/10/25 |